Generic Exclusivity Battles Now Extend To Brand-Authorized Versions: Mylan Blocks Launch Of Apotex's Paxil CR Copy
This article was originally published in The Pink Sheet Daily
Executive Summary
A court issued a temporary restraining order against Apotex and GlaxoSmithKline in response to Mylan's claims that it has sole rights to market generic Paxil CR under a licensing agreement with GSK.